Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:45 PM
Ignite Modification Date:
2025-12-24 @ 11:45 PM
NCT ID:
NCT00509951
Eligibility Criteria:
Inclusion Criteria:
* Enrolled in a regular classroom setting
* Possess at least an average intellectual ability as documented by school ability records
* Meets DSM-IV criteria for specific phobia and scores 4 or above on the clinician severity rating scale of the ADIS-C/P
* A parent or caregiver agrees to participate in the treatment
* Parent or guardian willing to provide informed consent
Exclusion Criteria:
* Significant medical disorder (e.g., cerebral palsy, deafness) that would interfere with study participation
* Already receiving psychological treatment (with the exception of minimal intervention in the school setting)
* Currently receiving psychotropic medication for a psychological disorder, with the exception of attention deficit hyperactivity disorder (ADHD). If the child is receiving stimulant or other medication for management of ADHD symptoms, it must be documented that pharmacological treatment has been stabilized.
* Blood-injection-injury type of specific phobia
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
7 Years
Maximum Age:
14 Years
Study:
NCT00509951
Study Brief:
Protocol Section:
NCT00509951